Naprometin
Naprometin is a medicine that relieves pain and inflammation, and lowers fever.
Form
tabletti
Strength
500 mg
Active Ingredient
Naproxen
Manufacturer
Atnahs Pharma Netherlands B.V.
How to Use
Dosage
Usually 250-500 mg twice a day. The dose depends on the condition being treated.
Method
You can take the tablets with or without food. Taking them with food might make the effect start slower.
Important
Do not take more than 1250 mg in one day.
Possible Side Effects
COMMON
- •Heartburn, stomach pain, nausea, vomiting, diarrhea, constipation.
- •Bleeding or ulcers in the digestive tract.
- •Bruising, itching, red spots on the skin.
- •Trouble sleeping.
- •Dizziness, headache, lightheadedness.
- •Vision problems.
- •Sudden rashes, allergic rashes, sweating.
- •Hearing loss, hearing problems, ringing in the ears, vertigo.
RARE
- •Holes in the digestive tract, vomiting blood, bloody stools, mouth sores, worsening of bowel diseases like colitis or Crohn's.
- •High potassium levels in the blood.
- •Depression, unusual dreams.
- •Optic nerve inflammation behind the eye, seizures, trouble concentrating.
- •Heart palpitations, fluid in the lungs, asthma attacks, a type of lung inflammation (eosinophilic pneumonia).
- •Abnormal liver tests, kidney problems (like kidney failure), increased creatinine levels in the blood.
- •Hair loss.
- •Female infertility, menstrual problems.
- •Thirst, general feeling of unwellness.
- •Clouding of the cornea, inflammation or swelling of the optic nerve head.
- •Skin reactions to light, such as flaky or blistering rashes.
- •Muscle pain, muscle weakness.
- •Salivary gland inflammation, pancreatitis.
- •Non-bacterial meningitis, fever, chills.
- •Blood cell changes (e.g., severe lack of white blood cells, various types of anemia, low platelet count).
- •Severe allergic reactions (such as swelling in the face/throat, trouble breathing).
- •Drowsiness.
- •Heart failure.
- •Blood clots (like heart attack or stroke), high blood pressure, inflammation of blood vessels.
- •Severe liver inflammation, yellowing of skin/eyes (jaundice).
- •Severe blistering skin reactions (like Stevens-Johnson syndrome, DRESS, toxic epidermal necrolysis, widespread blistering, lupus, hives).
- •Kidney tissue damage, blood in urine, other kidney diseases.
- •Skin reactions that reappear in the same spot each time you take the medicine.
Important Warnings
- Do not take if you are allergic to naproxen or any other ingredients in this medicine.
- Do not take if you have previously had an allergic reaction (like asthma or rash) from aspirin or similar painkillers.
- Do not take if you have or have had a stomach or duodenal ulcer, or bleeding in your digestive tract.
- Do not take if you have severe heart failure.
- Do not use during the last three months of pregnancy. Talk to your doctor if you are pregnant or planning to become pregnant.
Show 7 more warnings
- Not recommended during breastfeeding.
- Naprometin may slightly increase the risk of heart attack or stroke. This risk is higher with large doses and long-term use. Do not exceed the recommended dose or treatment time.
- Tell your doctor if you have heart problems, have had a stroke, or have risk factors (like high blood pressure, diabetes, high cholesterol, or smoking).
- Tell your doctor if you have or have had digestive tract ulcers, asthma, a higher tendency to bleed, or kidney or liver disease.
- Elderly patients are more likely to get side effects, especially bleeding or holes in the digestive tract. Long-term treatment is not recommended for elderly people.
- Do not give to children under 1 year of age.
- Do not use multiple painkillers at the same time unless your doctor tells you to.
Use in Elderly Patients
Category C
Suitable for older adults, with specific precautions. For short-term use only. Consider adverse renal effect in chronic kidney disease. Do not use in severe renal impairment. Increases swelling, worsens renal and heart failure and causes cardiovascular events. Increases risk of bleeding, especially in the gastrointestinal tract. Consider potential interactions especially with preparations that increase risk of bleeding. (updated 16.9.2024)